CORD BLOOD AMERICA, INC. (OTCMKTS:CBAI) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

CORD BLOOD AMERICA, INC. (OTCMKTS:CBAI) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 7.01 Departure of Directors of Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

The Board of Directors (the “Board”) of Cord Blood America, Inc. (the “Company”) announced that Stephen Morgan will resign from his positions as Interim President, General Counsel, and Corporate Secretary effective July 19, 2017, in order to pursue other career opportunities in his home state of Minnesota where he can devote more time to his family. Mr. Morgan will be available to assist with the transition and consult with the Company on an as needed basis.

Effective July 19, 2017, the Company’s board of directors has named Director and Chairman of the Audit Committee Anthony Snow as Interim President and Corporate Secretary. The Company shall pay Mr. Snow five thousand dollars ($5,000) per month while he serves as Interim President. Mr. Snow will not receive any fees for serving as a Director or as Chairman of the Audit Committee while he serves as Interim President.

Anthony Snow, age 41, has been a Director of the Company since April 2015.He is a Managing Director at Red Oak Partners. Prior to joining Red Oak, Mr. Snow worked at Soros Fund Management where he was part of a two person team that managed a global long/short equity portfolio. Prior to Soros, Mr. Snow focused on investments in global equities at both Ardea Capital Management, as part of the founding team, and Wyper Capital Management. Previously, Mr. Snow was employed at Lindsay Goldberg, a private equity firm, where he focused on leveraged buyouts. Mr. Snow began his career at Merrill Lynch & Co. as an Analyst in the Mergers & Acquisitions group. He received a B.B.A. with high distinction from the University of Michigan, concentrating in finance and accounting, and an M.B.A. from Harvard Business School. Mr. Snow is currently a Director and Chairman of the Finance Committee of StreetWise Partners, a New York City non-profit, and also serves on the Executive Committee.

There are no family relationships between Mr. Snow and any director or executive officer of the Company, or any person nominated or chosen by the Company to become a director or executive officer. There are no arrangements or understandings between Mr.Snow and any other persons to which he was selected as Interim President. Mr.Snow has no direct or indirect material interest in any transaction or currently proposed transaction required to be disclosed to Item404(a) of Regulation S-K.

Item 7.01 Regulation FD Disclosure.

The Company issued a press release (the “Press Release”) announcing Mr. Morgan’s resignation and the appointment of Mr.Snow as Interim President and Corporate Secretary.

The information furnished under this Item 7.01 on this Form 8-K, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 7.01Financial Statements and Exhibits.

(d) Exhibits

The following Exhibits are furnished herewith:

Cord Blood America, Inc. ExhibitEX-99.9 2 cbai_ex999.htm PRESS RELEASE Blueprint   Exhibit 99.9   Cord Blood America,…To view the full exhibit click here
About CORD BLOOD AMERICA, INC. (OTCMKTS:CBAI)
Cord Blood America, Inc. (CBAI), through its CorCell program and its subsidiary CorCell Companies, Inc., provides cord blood and cord tissue stem cell services. CBAI’s subsidiaries include Cord Partners, Inc., CorCell Companies, Inc., CorCell, Ltd., (Cord Partners, Inc., CorCell Companies, Inc. and CorCell, Ltd. are referred to collectively as Cord), CBA Properties, Inc. (Properties), and Career Channel, Inc. CBAI and its subsidiaries engage in the various business activities, such as CBAI and Cord specialize in providing private cord blood and cord tissue stem cell storage services to families throughout the United States and Puerto Rico, and Properties was formed to hold corporate trademarks and other intellectual property. Cord’s operations provide umbilical cord blood banking and cord tissue services to expectant parents. Cord provides various services, which includes collection materials, physician and customer support, transportation, testing and cord blood storage.